Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
Go back to Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies| Sunshine Biopharma, Inc. (NASDAQ: SBFM) | Delayed: 0.17 -0.05 (22.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.22 | 52 Week High | $0.04 | |||
| Open | $0.17 | 52 Week Low | $0.00 | |||
| Day High | $0.19 | P/E | N/A | |||
| Day Low | $0.16 | EPS | $0.00 | |||
| Volume | 3,116,739 | |||||



